Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy Post author:Sam Post published:February 7, 2018 Post category:BioPharma The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy. Source: BioSpace You Might Also Like STAAR Surgical And Announce Strategic Cooperation Agreement August 14, 2017 <b>Gottlieb</b> Lays Out Plans to Attract and Preserve Top Talent at the FDA July 17, 2017 FDA Just Rejected Eli Lilly, Incyte's Rheumatoid Arthritis Drug Baricitinib April 13, 2017
